1. Home
  2. NRXP vs HUBC Comparison

NRXP vs HUBC Comparison

Compare NRXP & HUBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • HUBC
  • Stock Information
  • Founded
  • NRXP 2015
  • HUBC 2017
  • Country
  • NRXP United States
  • HUBC Israel
  • Employees
  • NRXP N/A
  • HUBC N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • HUBC
  • Sector
  • NRXP Health Care
  • HUBC
  • Exchange
  • NRXP Nasdaq
  • HUBC Nasdaq
  • Market Cap
  • NRXP 48.5M
  • HUBC 15.2M
  • IPO Year
  • NRXP N/A
  • HUBC N/A
  • Fundamental
  • Price
  • NRXP $4.01
  • HUBC $0.81
  • Analyst Decision
  • NRXP Strong Buy
  • HUBC
  • Analyst Count
  • NRXP 3
  • HUBC 0
  • Target Price
  • NRXP $31.67
  • HUBC N/A
  • AVG Volume (30 Days)
  • NRXP 2.8M
  • HUBC 3.8M
  • Earning Date
  • NRXP 11-14-2024
  • HUBC 12-13-2024
  • Dividend Yield
  • NRXP N/A
  • HUBC N/A
  • EPS Growth
  • NRXP N/A
  • HUBC N/A
  • EPS
  • NRXP N/A
  • HUBC N/A
  • Revenue
  • NRXP N/A
  • HUBC $33,357,000.00
  • Revenue This Year
  • NRXP N/A
  • HUBC N/A
  • Revenue Next Year
  • NRXP N/A
  • HUBC N/A
  • P/E Ratio
  • NRXP N/A
  • HUBC N/A
  • Revenue Growth
  • NRXP N/A
  • HUBC N/A
  • 52 Week Low
  • NRXP $1.10
  • HUBC $0.37
  • 52 Week High
  • NRXP $7.33
  • HUBC $2.17
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 61.48
  • HUBC 58.71
  • Support Level
  • NRXP $3.20
  • HUBC $0.51
  • Resistance Level
  • NRXP $6.01
  • HUBC $0.92
  • Average True Range (ATR)
  • NRXP 0.95
  • HUBC 0.20
  • MACD
  • NRXP 0.11
  • HUBC 0.00
  • Stochastic Oscillator
  • NRXP 56.52
  • HUBC 44.09

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About HUBC Hub Cyber Security Ltd.

Hub Cyber Security Ltd is engaged in the development of cyber products, software, quality systems, reliability, and risk management. It operates in several countries and provides cybersecurity computing appliances as well as a wide range of cybersecurity professional services. The company has two operating segments: the Product and Technology Segment, and the Professional Services Segment. The majority of its revenue comes from the professional services segment, which provides data and cybersecurity, system security and reliability solutions, as well as related services such as consulting, planning, training, integration, and ongoing servicing of cybersecurity, risk management, system quality, reliability, and security projects, including fully managed corporate cybersecurity services.

Share on Social Networks: